Consultative session at the Islamabad Healthcare Regulatory Authority (IHRA)

/in /by
 CEO of IHRA, chaired a consultative session at the Islamabad Healthcare Regulatory Authority (IHRA) alongside representatives from DRAP and other departments.
The meeting aimed Agenda for meeting:
1. Discussion on IHRA’s draft of regenerative medicine MSDS to review and comment on the draft.
2.IHRA will provide them one window operation to the clients dealing with Regenerative medicine.